Dose-response range of encainide for benign and potentially lethal ventricular arrhythmias
- 1 April 1986
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 57 (10) , 769-774
- https://doi.org/10.1016/0002-9149(86)90611-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Premature Ventricular ComplexesPublished by American Medical Association (AMA) ,1984
- Flecainide: Its proarrhythmic effect and expected changes on the surface electrocardiogramThe American Journal of Cardiology, 1984
- Clinical importance of metabolites of antiarrhythmic drugsThe American Journal of Cardiology, 1984
- Encainide for refractory ventricular tachyarrhythmiaThe American Journal of Cardiology, 1983
- Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial.Circulation, 1983
- Treatment of frequent ventricular arrhythmia with encainide: assessment using serial ambulatory electrocardiograms, intracardiac electrophysiologic studies, treadmill exercise tests, and radionuclide cineangiographic studies.Circulation, 1982
- Electrophysiology of oral encainideThe American Journal of Cardiology, 1982
- Metabolite cumulation during long-term oral encainide administrationClinical Pharmacology & Therapeutics, 1982
- The cooperative encainide trial: Efficacy, tolerance and dose findings in chronic severe ventricular ectopyThe American Journal of Cardiology, 1982
- Total Suppression of Ventricular Arrhythmias by EncainideNew England Journal of Medicine, 1980